Cargando…

Involvement of mTOR Pathways in Recovery from Spinal Cord Injury by Modulation of Autophagy and Immune Response

Traumatic spinal cord injury (SCI) is untreatable and remains the leading cause of disability. Neuroprotection and recovery after SCI can be partially achieved by rapamycin (RAPA) treatment, an inhibitor of mTORC1, complex 1 of the mammalian target of rapamycin (mTOR) pathway. However, mechanisms re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vargova, Ingrid, Machova Urdzikova, Lucia, Karova, Kristyna, Smejkalova, Barbora, Sursal, Tolga, Cimermanova, Veronika, Turnovcova, Karolina, Gandhi, Chirag D., Jhanwar-Uniyal, Meena, Jendelova, Pavla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225190/ https://www.ncbi.nlm.nih.gov/pubmed/34073791 http://dx.doi.org/10.3390/biomedicines9060593

Ejemplares similares

The Role of Green Tea Catechin Epigallocatechin Gallate (EGCG) and Mammalian Target of Rapamycin (mTOR) Inhibitor PP242 (Torkinib) in the Treatment of Spinal Cord Injury
por: Machova Urdzikova, Lucia, et al.
Publicado: (2023)

Transplantation of neural precursors generated from spinal progenitor cells reduces inflammation in spinal cord injury via NF-κB pathway inhibition
por: Karova, Kristyna, et al.
Publicado: (2019)

Does combined therapy of curcumin and epigallocatechin gallate have a synergistic neuroprotective effect against spinal cord injury?
por: Ruzicka, Jiri, et al.
Publicado: (2018)

Human Mesenchymal Stem Cells Modulate Inflammatory Cytokines after Spinal Cord Injury in Rat
por: Machová Urdzíková, Lucia, et al.
Publicado: (2014)

The Anti-Inflammatory Compound Curcumin Enhances Locomotor and Sensory Recovery after Spinal Cord Injury in Rats by Immunomodulation
por: Machova Urdzikova, Lucia, et al.
Publicado: (2015)

Targeting the mTOR pathway using novel ATP-competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
por: Amin, Anubhav G., et al.
Publicado: (2021)

The effect of 808 nm and 905 nm wavelength light on recovery after spinal cord injury
por: Svobodova, Barbora, et al.
Publicado: (2019)

The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury
por: Chudickova, Milada, et al.
Publicado: (2019)

Metabolic Changes in Focal Brain Ischemia in Rats Treated With Human Induced Pluripotent Stem Cell-Derived Neural Precursors Confirm the Beneficial Effect of Transplanted Cells
por: Jirak, Daniel, et al.
Publicado: (2019)

New Model of Ventral Spinal Cord Lesion Induced by Balloon Compression in Rats
por: Krupa, Petr, et al.
Publicado: (2020)

Modified Methacrylate Hydrogels Improve Tissue Repair after Spinal Cord Injury
por: Hejčl, Aleš, et al.
Publicado: (2018)

The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application
por: Krupa, Petr, et al.
Publicado: (2018)

Planet of the AAVs: The Spinal Cord Injury Episode
por: Stepankova, Katerina, et al.
Publicado: (2021)

4-Methylumbeliferone Treatment at a Dose of 1.2 g/kg/Day Is Safe for Long-Term Usage in Rats
por: Štěpánková, Kateřina, et al.
Publicado: (2023)

Neurogenesis as a Tool for Spinal Cord Injury
por: Havelikova, Katerina, et al.
Publicado: (2022)

Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
por: Amemori, Takashi, et al.
Publicado: (2015)

The Effect of iPS-Derived Neural Progenitors Seeded on Laminin-Coated pHEMA-MOETACl Hydrogel with Dual Porosity in a Rat Model of Chronic Spinal Cord Injury
por: Ruzicka, Jiri, et al.
Publicado: (2019)

Comparison of intraspinal and intrathecal implantation of induced pluripotent stem cell-derived neural precursors for the treatment of spinal cord injury in rats
por: Amemori, Takashi, et al.
Publicado: (2015)

A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1(G93A) Rats
por: Řehořová, Monika, et al.
Publicado: (2019)

The effects of grafted mesenchymal stem cells labeled with iron oxide or cobalt-zinc-iron nanoparticles on the biological macromolecules of rat brain tissue extracts
por: Novotna, Bozena, et al.
Publicado: (2017)

Intrathecal Delivery of Mesenchymal Stromal Cells Protects the Structure of Altered Perineuronal Nets in SOD1 Rats and Amends the Course of ALS
por: Forostyak, Serhiy, et al.
Publicado: (2014)

Human multipotent mesenchymal stem cells improve healing after collagenase tendon injury in the rat
por: Machova Urdzikova, Lucia, et al.
Publicado: (2014)

Low oral dose of 4-methylumbelliferone reduces glial scar but is insufficient to induce functional recovery after spinal cord injury
por: Štepánková, Kateřina, et al.
Publicado: (2023)

Chemical and Colloidal Stability of Polymer-Coated NaYF(4):Yb,Er Nanoparticles in Aqueous Media and Viability of Cells: The Effect of a Protective Coating
por: Nahorniak, Mykhailo, et al.
Publicado: (2023)

Polymer-coated hexagonal upconverting nanoparticles: chemical stability and cytotoxicity
por: Patsula, Vitalii, et al.
Publicado: (2023)

Long-Term Cultures of Spinal Cord Interneurons
por: Vargova, Ingrid, et al.
Publicado: (2022)

The effect of magnetic nanoparticles on neuronal differentiation of induced pluripotent stem cell-derived neural precursors
por: Jiráková, Klára, et al.
Publicado: (2016)

Manganese‐Zinc Ferrites: Safe and Efficient Nanolabels for Cell Imaging and Tracking In Vivo
por: Herynek, Vít, et al.
Publicado: (2019)

Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat
por: Amemori, Takashi, et al.
Publicado: (2013)

Using ferromagnetic nanoparticles with low Curie temperature for magnetic resonance imaging-guided thermoablation
por: Herynek, Vít, et al.
Publicado: (2016)

An evaluation of the effect of equine-facilitated psychotherapy on patients with substance use disorders
por: Machová, Kristýna, et al.
Publicado: (2023)

MBRS-18. TUMOR SUPPRESSOR p53 DEFINES THE THERAPEUTIC RESPONSES IN TREATMENT OF MEDULLOBLASTOMA
por: Mohan, Avinash L, et al.
Publicado: (2020)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Therapeutic Strategies for Spinal Cord Injury
por: Jendelova, Pavla
Publicado: (2018)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
por: Jhanwar-Uniyal, Meena, et al.
Publicado: (2015)

Validation of the Human–Animal Interaction Scale (HAIS) in Czech Language
por: Machová, Kristýna, et al.
Publicado: (2020)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ttl833hqf3vdho8u9troab3oip